and teams – step out of your comfort zone and prove your abilities. Organiser PharmaTimes Media calls on clinical researchers to
enter this prestigious competition and take advantage of a unique career
Kidney cancer patients are now likely to get access to Bristol-Myers Sqiubb's immunotherapy on the NHS in England and Wales after all, as cost regulators have a change of heart and recommended the drug.
The Zika outbreak has brought the issue of congenital anomalies to the forefront of the science community and the public's mind. We ask Helen Dolk, Professor of Epidemiology at the University of Ulster, about the challenges of working in this area